The legislation that would shield banks, credit unions, and other financial institutions from federal penalties for serving state-licensed cannabis businesses has been reintroduced in the 119th Congress. For cannabis operators who have been managing the cash-heavy, underbanked reality of the industry for years, this is a familiar headline — and a familiar exercise in managed expectations.
- Congress has reintroduced the SAFE Banking Act with bipartisan Senate and House sponsors.
- The bill would create clearer protections for financial institutions serving state-legal cannabis businesses.
- Schedule III status for qualifying medical marijuana does not itself create a banking safe harbor.
- SAFE Banking has passed the House repeatedly but has never reached a Senate floor vote.
- Operators should continue building banking relationships available under the current framework.
The Secure and Fair Enforcement (SAFE) Banking Act of 2026 is a bicameral reintroduction led in the Senate by Jeff Merkley (D-Ore.), Lisa Murkowski (R-Alaska), Elizabeth Warren (D-Mass.), and Steve Daines (R-Mont.), and in the House by Dave Joyce (R-Ohio) and a bipartisan group of colleagues. The bill’s protections extend beyond banks to certain credit unions, insurers, lenders, and service providers that work with state-sanctioned medical or adult-use cannabis businesses.
This is not the bill’s first trip through the hallowed halls of Congress. SAFE Banking has been here before. Many times.
The legislative history
SAFE Banking has passed the House seven times since 2019, often with bipartisan support. Senate companion legislation has been introduced repeatedly, but no version has received a Senate floor vote or reached the president’s desk.
The Senate’s closest approach came in 2023, when senators introduced the revised Secure and Fair Enforcement Regulation (SAFER) Banking Act. The measure expanded protections for ancillary businesses and insurers and added diversity-and-inclusion reporting provisions. It passed the Senate Banking Committee 14–9 but failed to receive a Senate floor vote before the 118th Congress ended.
The core problem SAFE Banking addresses has not been resolved by other federal action. Because cannabis activity remains federally regulated and, for most businesses, federally prohibited, financial institutions face continuing anti-money-laundering, Bank Secrecy Act (BSA), suspicious-activity-reporting (SAR), and prudential-regulatory risk when serving cannabis businesses. The bill would create an explicit federal safe harbor that current guidance does not provide.
Financial Crimes Enforcement Network (FinCEN) guidance issued in 2014 explains how financial institutions may serve marijuana-related businesses while meeting BSA obligations, including enhanced due diligence and SAR filing requirements. It is compliance guidance, not a statutory safe harbor or an obligation for banks to take cannabis clients.
What Schedule III changes — and what it doesn’t
The Blanche Order, effective April 28, 2026, placed marijuana products approved by the Food and Drug Administration and marijuana products subject to qualifying state-issued medical licenses in Schedule III. That is significant. It is not, however, a complete solution to the banking problem. A medical-cannabis operator covered by the order may now handle a Schedule III controlled substance, but that change does not itself create a banking safe harbor.
Rescheduling does not eliminate Bank Secrecy Act, anti-money-laundering, or prudential obligations, and it does not require federally insured institutions to serve cannabis businesses. Federal controls, licensing requirements, and banking-compliance obligations remain. No banking regulator has updated formal guidance to address the Blanche Order’s implications for cannabis banking.
The statutory fix remains a statutory fix. Without explicit safe-harbor legislation, the legal exposure that has kept many large financial institutions out of the cannabis market persists.
What’s different and what stays the same
Proponents point to the rescheduling context: Cannabis banking is no longer an argument for legalizing a Schedule I substance. It is, in part, an argument about providing normal financial services to certain state-regulated medical-cannabis businesses whose products now fall within Schedule III under the Blanche Order. That framing may be more palatable to reluctant senators.
Historically, bipartisan co-sponsorship has been SAFE Banking’s strongest asset, with consistent Republican co-sponsors distinguishing the banking bill from broader legalization legislation.
The structural obstacle has not changed. No version of SAFE Banking has reached a Senate floor vote, much less demonstrated the 60 votes generally needed to overcome a filibuster. The House has been the easier chamber; the Senate has been the wall. Nothing in the current legislative environment confirms the wall has moved.
What operators should watch
• Committee action: SAFE Banking must clear committees in both chambers. Senate Banking Committee action will be the earliest indicator of whether this session is different.
• Senate co-sponsors: The number and party affiliation at introduction is a leading indicator of whether the bill has the votes to advance.
• Financial strategy: Do not model your financial services strategy around SAFE Banking’s passage. Operators who have built functional banking relationships under the current FinCEN framework should continue working within that framework. Pursue the relationships available now — banks and credit unions with established cannabis-banking programs, including institutions operating in cannabis-friendly states — rather than waiting for federal legislation that may not arrive this session.
• Regulatory guidance: Watch for rescheduling-linked guidance from banking regulators. If the Office of the Comptroller of the Currency (OCC), Federal Deposit Insurance Corporation (FDIC), or Federal Reserve issues updated guidance on cannabis banking post-Schedule III, that would be meaningful even without SAFE Banking. As of July 1, 2026, the agencies have not publicly announced cannabis-specific post-order revisions to FinCEN, OCC, FDIC, or Federal Reserve guidance.
SAFE Banking is back. Whether this round will end in a different result is the right question. The honest answer, based on the legislative record, is “possibly, at the margin, and not yet demonstrably so.” Operators should root for it and plan around its absence.
